Elucidating the in vivo targets of bacterial toxins

Future Microbiology

Volumn 2, Issue 1, 2007, Pages 85-92

  Hamm, Elaine E ^a   Ballard, Jimmy D ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Bacterial toxins; Clostridium difficile; Clostridium difficile toxin B; Intracellular bacterial toxins; Microbial pathogens; Virulence; Zebrafish

Indexed keywords

BACTERIAL TOXIN; CLOSTRIDIUM DIFFICILE TOXIN B; VIRULENCE FACTOR;

CELL CULTURE; CELL DAMAGE; CELL TYPE; CLOSTRIDIUM DIFFICILE; HEART; HOST CELL; IN VITRO STUDY; INTOXICATION; METABOLISM; MICROBIAL ACTIVITY; MICROSCOPY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN SECRETION; REVIEW; ZEBRA FISH;

ANIMALS; BACTERIAL PROTEINS; BACTERIAL TOXINS; EMBRYO, NONMAMMALIAN; FEMALE; HEART; MALE; MYOCARDIUM; ZEBRAFISH;

ANIMALIA; BACTERIA (MICROORGANISMS); CLOSTRIDIUM DIFFICILE; DANIO RERIO;

EID: 34248673996     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460913.2.1.85     Document Type: Review

References (56)

1. Cossart P, Vicente MF, Mengaud J, Baquero F, Perez-Diaz JC, Berche P: Listeriolysin O is essential for virulence of Listeria monocytogenes: direct evidence obtained by gene complementation. Infect. Immun. 57(11), 3629-3636 (1989).
2. Gross MK, Au DC, Smith AL, Storm DR: Targeted mutations that ablate either the adenylate cyclase or hemolysin function of the bifunctional cyaA toxin of Bordetella pertussis abolish virulence. Proc. Natl Acad. Sci. USA 89(11), 4898-4902 (1992).
3. Pierce NF, Kaper JB, Mekalanos JJ, Cray WC Jr: Role of cholera toxin in enteric colonization by Nobrio cholerae O1 in rabbits. Infect. Immun. 50(3), 813-816 (1985).
4. von Behring E, Kitasato S: Ueber das Zustandekommen der Diphtherie-Immunitat und der Tetanus-Immunitat bei Thieren. Microbiol. Rev. 28(12), 1317 (1890).
5. Glenny AT, Hopkins BE: Diphtheria toxoid as an immunising agent. Brit. J. Exp. Path. 4, 283-288 (1923).
6. Ramon GaZ, C: L'anatoxine totanique et l'immunisation active de l'homme vis-a-vis du totanos. Ann. Inst. Pasteur. 41, 803 (1927).
7. Tweten RK: Cholesterol-dependent cytolysins, a family of versatile pore-forming toxins. Infect. Immun. 73(10), 6199-6209 (2005).
8. Titball RW: Bacterial phospholipases C. Microbiol. Rev. 57(2), 347-366 (1993).
9. Schmitt CK, Meysick KC, O'Brien AD: Bacterial toxins: friends or foes? Emerg. Infect. Dis. 5(2), 224-234 (1999).
10. Schirmer J, Aktories K: Large clostridial cytotoxins: cellular biology of Rho/Rasglucosylating toxins. Biochem. Biophys. Acta. 1673(1-2), 66-74 (2004).
11. Chuang TH, Hahn KM, Lee JD, Danley DE, Bokoch GM: The small GTPase Cdc42 initiates an apoptotic signaling pathway in Jurkat T lymphocytes Mol. Biol. Cell. 8(9), 1687-1698 (1997).
12. Embade N, Valeron PF, Aznar S, Lopez-Collazo E, Lacal JC: Apoptosis induced by Rac GTPase correlates with induction of FasL and ceramides production. Mol. Biol. Cell. 11 (12), 4347-4358 (2000).
13. Jin S, Ray RM, Johnson LR: Rac1 mediates intestinal epithelial cell apoptosis via JNK. Am. J. Physiol. Gastrointest. Liver Physiol. 291(6), G1137-G1147 (2006).
14. Zhang B, Zhang Y, Shacter E: Rac1 inhibits apoptosis in human lymphoma cells by stimulating Bad phosphorylation on Ser-75. Mol. Cell Biol. 24 (14), 6205-6214 (2004).
15. Tweten RK: The thiol-activated clostridia toxins. In: The Clostridia: Molecular Biology and Pathogenesis. Rood JI (Ed.). Academic Press, CA, USA, 211-221 (1997).
16. Giddings KS, Johnson AE, Tweten RK: Redefining cholesterol's role in the mechanism of the cholesterol-dependent cytolysins. Proc. Natl Acad. Sci. USA 100(20), 11315-11320 (2003).
17. Waheed AA, Shimada Y, Heijnen HF et al.: Selective binding of perfringolysin O derivative to cholesterol-rich membrane microdomains (rafts). Proc. Natl Acad. Sci. USA 98(9), 4926-4931 (2001).
18. Shimada Y, Nakamura M, Naito Y, Nomura K, Ohno-Iwashita Y: C-terminal amino acid residues are required for the folding and cholesterol binding property of perfringolysin O, a pore-forming cytolysin. J. Blol. Chem. 274(26), 18536-18542 (1999).
19. Iwamoto M, Nakamura M, Mitsui K, Ando S, Ohno-Iwashita Y: Membrane disorganization induced by perfringolysin O (θ-toxin) of Clostridium perfringens-effect of toxin binding and self-assembly on liposomes. Biochem. Biophys. Acta. 1153(1), 89-96 (1993).
20. Simpson LL: Botulinum Neurotoxin and Tetanus Toxin. Simpson LL (Ed.). Academic Press, CA, USA (1989).
21. Schiavo, G: The structure and mode of action of botulinum and tetanus toxins. In: The Clostridia: Molecular Biology and Pathogenesis. Rood JI, McClane BA, Songer JG, Titball RW (Ed.). Academic Press, CA, USA, 295-322 (1997).
22. Arnon S: Human tetanus and human botulism. In: The Clostridia: Molecular Biology and Pathogenesis. Rood JI, McClane BA, Songer JG, Titball RW (Ed.). Academic Press, CA, USA, 95-115 (1997).
23. Galan JE: Bacterial toxins and the immune system: show me the in vivo targets. J. Exp. Med. 201(3), 321-323 (2005).
24. Johnson S, Kent SA, O'Leary KJ et al.: Fatal pseudomembranous colitis associated with a variant clostridium difficile strain not detected by toxin A immunoassay. Ann. Intern. Med. 135(6), 434-438 (2001).
25. Jacob SS, Sebastian JC, Hiorns D, Jacob S, Mukerjee PK: Clostridium difficile and acute respiratory distress syndrome. Heart Lung. 33(4), 265-268 (2004).
26. Dobson G, Hickey C, Trinder J: Clostridium difficile colitis causing toxic megacolon, severe sepsis and multiple organ dysfunction syndrome. Intensive Care Med. 29 (6), 1030 (2003).
27. Cunney RJ, Magee C, McNamara E, Smyth EG, Walshe J: Clostridium difficile colitis associated with chronic renal failure. Nephrol. Dial. Transplant. 13(11), 2842-2846 (1998).
28. Sakurai T, Hajiro K, Takakuwa, H, Nishi A, Aihara M, Chiba T. Liver abscess caused by Clostridium difficile. Scand. J. Infect. Dis. 33(1), 69-70 (2001).
29. Voth DE, Ballard JD: Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol. Rev. 18(2), 247-263 (2005).
30. Just I, Wilm M, Selzer J et al.: The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins. J. Biol. Chem. 270(23), 13932-13936 (1995).
31. Just I, Selzer J, Wilm M, von Eichel-Streiber C, Mann M, Aktories K: Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 375(6531), 500-503 (1995).
32. Boquet P: Bacterial toxins inhibiting or activating small GTP-binding proteins. Ann NY Acad Sci. 886(83-90 (1999).
33. Chang TW, Lin PS, Gorbach SL, Bartlett JG: Ultrastructural changes of cultured human amnion cells by Clostridium difficile toxin. Infect. Immun. 23(3), 795-798 (1979).
34. Qa'Dan M, Ramsey M, Daniel J et al.: Clostridium difficile toxin B activates dual caspase-dependent and caspase-independent apoptosis in intoxicated cells. Cell Microbiol. 4(7), 425-434 (2002).
35. Donta ST, Sullivan N, Wilkins TD: Differential effects of Clostridium difficile toxins on tissue-cultured cells. J. Clin. Microbiol. 15(6), 1157-1158 (1982).
36. Lyerly DM, Saum KE, MacDonald DK, Wilkins TD: Effects of Clostridium difficile toxins given intragastrically to animals. Infect. Immun. 47(2). 349-352 (1985).
37. Tucker AE, Salles II, Voth DE et al.: Decreased glycogen synthase kinase 3-beta levels and related physiological changes in Bacillus anthracis lethal toxin-treated macrophages. Cell Microbiol. 5(8), 523-532 (2003).
38. Voth DE, Hamm EE, Nguyen LG et al.: Bacillus anthracis oedema toxin as a cause of tissue necrosis and cell type-specific cytotoxicity. Cell Microbiol. 7(8), 1139-1149 (2005).
39. Hamm EE, Voth DE, Ballard JD: Identification of Clostridium difficile toxin B cardiotoxicity using a zebrafish embryo model of intoxication. Proc. Natl Acad. Sci. USA 103(38), 14176-14181 (2006).
40. Kumar S, Hedges SB: A molecular timescale for vertebrate evolution. Nature 392(6679), 917-920 (1998).
41. Langheinrich U: Zebrafish: a new model on the pharmaceutical catwalk. Bioessays 25(9), 904-912 (2003).
42. Streisinger G, Walker C, Dower N, Knauber D, Singer F: Production of clones of homozygous diploid zebra fish (Brachydanio rerio. Nature 291(5813), 293-296 (1981).
43. Grunwald DJ, Eisen JS: Headwaters of the zebrafish- emergence of a new model vertebrate. Nat. Rev. Genet. 3(9), 717-724 (2002).
44. Grabher C, Look AT: Fishing for cancer models. Nat. Biotechnol. 24(1), 45-46 (2006).
45. Pradel E, Ewbank JJ: Genetic models in pathogenesis. Annu. Rev. Genet. 38, 347-363 (2004).
46. Davis JM, Clay H, Lewis JL, Ghori N, Herbomel P, Ramakrishnan L: Real-time visualization of mycobacterium-macrophage interactions leading to initiation of granuloma formation in zebrafish embryos. Immunity 17(6), 693-702 (2002).
47. Miller JD, Neely MN: Zebrafish as a model host for streptococcal pathogenesis. Acta Trop. 91(1), 53-68 (2004).
48. Prouty MG, Correa NE, Barker LP, Jagadeeswaran P, Klose KE: Zebrafish-Mycobacterium marinum model for mycobacterial pathogenesis. FEMS Microbiol. Lett. 225(2), 177-182 (2003).
49. Neely MN, Pfeifer JD, Caparon M: Streptococcus-zebrafish model of bacterial pathogenesis. Infect. Immun. 70(7), 3904-3914 (2002).
50. van der Sar AM, Musters RJ, van Eeden FJ, Appelmelk BJ, Vandenbroucke-Grauls CM, Bitter W: Zebrafish embryos as a model host for the real time analysis of Salmonella typhimurium infections. Cell Microbiol. 5(9), 601-611 (2003).
51. van der Sar AM, Appelmelk BJ, Vandenbroucke-Grauls CM, Bitter W: A star with stripes: zebrafish as an infection model. Trends Microbiol. 12(10), 451-457 (2004).
52. Parng C: In vivo zebrafish assays for toxicity testing. Curr. Opin. Drug Discov. Devel. 8(1), 100-106 (2005).
53. Hill AJ, Teraoka H, Heideman W, Peterson RE: Zebrafish as a model vertebrate for Investigating chemical toxicity. Toxicol. Sci. 86(1), 6-19 (2005).
54. Stainier DY: Zebrafish genetics and vertebrate heart formation. Nat. Rev. Genet. 2(1), 39-48 (2001).
55. Lawson ND, Weinstein BM: In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev. Biol. 248(2), 307-318 (2002).
56. Roux E, Yersin A: Contribution a l'etude de la diphtherie. Ann. Inst. Pasteur. 2, 629-661 (1888).